Invention Grant
- Patent Title: CD8 polypeptides, compositions, and methods of using thereof
-
Application No.: US17563599Application Date: 2021-12-28
-
Publication No.: US12234473B2Publication Date: 2025-02-25
- Inventor: Gagan Bajwa , Mamta Kalra , Melinda Mata
- Applicant: Immatics US, Inc.
- Applicant Address: US TX Houston
- Assignee: Immatics US, Inc.
- Current Assignee: Immatics US, Inc.
- Current Assignee Address: US TX Houston
- Agency: McBee, Moore & Vanik IP, LLC
- Priority: DE102021100038.6 20210104
- Main IPC: A61K35/17
- IPC: A61K35/17 ; A61K39/00 ; C07K14/705 ; C07K14/725 ; C12N5/0783 ; C12N15/86
Abstract:
The present disclosure relates to T cells capable of co-expressing T cell receptors (“TCR”) together with CD8 polypeptides and the use thereof in adoptive cellular therapy. The present disclosure further provides for modified CD8 sequences, vectors, and associated methods thereof.
Public/Granted literature
- US20220202862A1 CD8 POLYPEPTIDES, COMPOSITIONS, AND METHODS OF USING THEREOF Public/Granted day:2022-06-30
Information query
IPC分类:
